FDA Clearance Tracker · K220846
CORE-SNARE
Last checked: Nov 20, 2026Latest source record: Nov 21, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Nov 21, 2022
Substantially Equivalent
Time to decision
243 days
Received Mar 23, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K220846
- Device name
- CORE-SNARE
- Applicant
- Incore Co., Ltd.
- Applicant location
- Daegu, KR
- Received
- Mar 23, 2022
- Decided
- Nov 21, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Snare, Flexible (FDI)
- Device class
- Class II
- Regulation
- 21 CFR 876.4300
- Specialty
- GI, Urology & Nephrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FDI. The earliest in FDA's data is K845016, decided Jan 15, 1985.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K220846
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Incore Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232216 · Decided Apr 19, 2024 · 268 days after receipt
Device type: Hemostatic Wound Dressing Without Thrombin Or Other Biologics (QSY) · General & Plastic Surgery
- CORE-INJECTOR510(k)
K221054 · Decided Dec 21, 2022 · 254 days after receipt
Device type: Endoscopic Injection Needle, Gastroenterology-Urology (FBK) · GI, Urology & Nephrology
- CORE-SPORT510(k)
K220081 · Decided Sep 28, 2022 · 261 days after receipt
Device type: Laparoscopic Single Port Access Device (OTJ) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.